drugset

drugset / Trial / NCT06762119

A Study of CAR-T Cells in Subjects with Autoimmune Diseases

NCT06762119 ↗

Phase 0 Not yet recruiting 6 enrolled Zhejiang University

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in Subjects with autoimmune diseases.

Timeline

Start: 2025-01-10
Primary completion: 2027-08-05
Completion: 2027-11-15

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CAR-T cell	Cell therapy	—	—

Indications